The prevalence of type 2 diabetes is growing at an alarming rate with past forecasts being exceeded years before predicted. In 2017, over 420 million people were living with diabetes and this number is expected to continue rising with the increasing levels of obesity seen in populations around the world.
However, effective treatment alternatives are available to reduce the burden and manage the risk of complications of type 2 diabetes. Explore the type 2 diabetes section for expert insights into the future of diabetes, the need to address clinical inertia, and view a range of Novartis-sponsored webinar topics.
Jump to each section by clicking below or continue scrolling down. The next page will load automatically.
How is the epidemiology of type 2 diabetes changing? Take a closer look at diabetes from the discovery of the first DPP-4 inhibitor publications marking 10 years of vildagliptin, and what the future might hold.
What are the barriers to optimised diabetes care? Find out how you can work better together with patients so they avoid learning about a complication the hard way. Watch the presentations from Dr David Strain, Dr Päivi Paldánius, Sir Michael Hirst plus patient insights to find out how it’s possible to combat clinical inertia in the management of type 2 diabetes.
Watch a webinar series exploring the management of type 2 diabetes in female patients during the different stages of life, consisting of three presentations including 'The octogenarian female patient' and 'The dynamic and hormonal' and an interactive panel discussion.
Alternatively login via
Back to epgonline.org